Analysis of signaling pathways indicated that the therapeutic mechanism of STS may engage the phosphatidylinositol signaling system, the PI3K-Akt signaling pathway, and the HIF-1 signaling pathway; additionally, enrichment results suggested that STS may be beneficial in treating sleep disorders and depression post-stroke. Here, AKT1 is linked to depressive symptom measurement.